Computer-Selected Antiviral Compounds: Assessing In Vitro Efficacies against Rift Valley Fever Virus
Rift Valley fever is a zoonotic viral disease transmitted by mosquitoes, impacting both humans and livestock. Currently, there are no approved vaccines or antiviral treatments for humans. This study aimed to evaluate the in vitro efficacy of chemical compounds targeting the Gc fusion mechanism. Thes...
Main Authors: | Cigdem Alkan, Terrence O’Brien, Victor Kenyon, Tetsuro Ikegami |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-01-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/16/1/88 |
Similar Items
-
An Overview of Rift Valley Fever Vaccine Development Strategies
by: Paul Kato Kitandwe, et al.
Published: (2022-10-01) -
Novel nomograms to predict risk and prognosis in hospitalized patients with severe fever with thrombocytopenia syndrome
by: Zhenxing Li, et al.
Published: (2023-12-01) -
Heartland Virus Disease—An Underreported Emerging Infection
by: Zygmunt F. Dembek, et al.
Published: (2024-01-01) -
Emerging Rift Valley fever in China: What should be known?
by: Viroj Wiwanitkit
Published: (2016-09-01) -
Experimental Infection of Calves by Two Genetically-Distinct Strains of Rift Valley Fever Virus
by: William C. Wilson, et al.
Published: (2016-05-01)